ACHC RSI Chart
Last 7 days
-8.8%
Last 30 days
-11.2%
Last 90 days
-15.3%
Trailing 12 Months
-2.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 3.0B | 0 | 0 | 0 |
2023 | 2.7B | 2.8B | 2.9B | 2.9B |
2022 | 2.4B | 2.4B | 2.5B | 2.6B |
2021 | 2.1B | 2.2B | 2.3B | 2.3B |
2020 | 2.0B | 2.0B | 2.0B | 2.1B |
2019 | 2.8B | 2.5B | 2.3B | 2.0B |
2018 | 2.9B | 2.9B | 3.0B | 3.0B |
2017 | 2.9B | 2.8B | 2.8B | 2.8B |
2016 | 2.0B | 2.3B | 2.6B | 2.8B |
2015 | 1.2B | 1.4B | 1.6B | 1.8B |
2014 | 753.6M | 789.9M | 899.7M | 1.0B |
2013 | 479.1M | 556.1M | 637.7M | 713.4M |
2012 | 274.0M | 328.4M | 370.1M | 407.5M |
2011 | 103.2M | 142.0M | 180.9M | 219.7M |
2010 | 55.0M | 58.1M | 61.2M | 64.3M |
2009 | 0 | 0 | 0 | 51.8M |
2008 | 0 | 0 | 0 | 33.4M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 23, 2024 | hollinsworth john s. | sold (taxes) | -38,783 | 70.26 | -552 | evp of operations |
Apr 11, 2024 | hollinsworth john s. | sold (taxes) | -37,596 | 75.8 | -496 | evp of operations |
Apr 11, 2024 | hunter christopher h. | sold (taxes) | -112,563 | 75.8 | -1,485 | chief executive officer |
Mar 24, 2024 | hollinsworth john s. | sold (taxes) | -214,401 | 76.49 | -2,803 | evp of operations |
Mar 05, 2024 | miquelon wade d | sold | -188,114 | 85.39 | -2,203 | - |
Mar 04, 2024 | gregg vicky b | sold | -213,900 | 85.56 | -2,500 | - |
Feb 28, 2024 | hollinsworth john s. | acquired | - | - | 47,550 | evp of operations |
Feb 28, 2024 | dixon heather brianne | acquired | - | - | 21,560 | chief financial officer |
Feb 28, 2024 | farley brian | acquired | - | - | 4,680 | evp , gc and secretary |
Feb 28, 2024 | hollinsworth john s. | sold (taxes) | -959,028 | 83.43 | -11,495 | evp of operations |
Which funds bought or sold ACHC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | VitalStone Financial, LLC | new | - | 8,000 | 8,000 | 0.01% |
May 06, 2024 | HighTower Advisors, LLC | reduced | -42.83 | -158,000 | 223,000 | -% |
May 06, 2024 | Candriam S.C.A. | sold off | -100 | -856,876 | - | -% |
May 06, 2024 | Parallel Advisors, LLC | unchanged | - | 86.00 | 4,674 | -% |
May 06, 2024 | DiNuzzo Private Wealth, Inc. | added | 12.5 | 181 | 1,426 | -% |
May 06, 2024 | Quantbot Technologies LP | new | - | 191,158 | 191,158 | 0.01% |
May 06, 2024 | SG Americas Securities, LLC | reduced | -58.94 | -374,000 | 270,000 | -% |
May 06, 2024 | NEW YORK LIFE INVESTMENT MANAGEMENT LLC | reduced | -2.7 | -7,338 | 829,671 | 0.01% |
May 06, 2024 | TEACHER RETIREMENT SYSTEM OF TEXAS | reduced | -10.24 | -132,000 | 1,407,000 | 0.01% |
May 06, 2024 | Envestnet Portfolio Solutions, Inc. | added | 2.36 | 15,666 | 381,682 | -% |
Unveiling Acadia Healthcare Co Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Acadia Healthcare Co Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 462.0B | 371.6B | 20.64 | 1.24 | ||||
CI | 98.5B | 206.0B | 25.56 | 0.48 | ||||
HCA | 82.4B | 66.7B | 15.06 | 1.23 | ||||
CVS | 70.0B | 360.9B | 9.55 | 0.19 | ||||
CNC | 40.5B | 155.5B | 14.81 | 0.26 | ||||
DVA | 12.1B | 12.3B | 14.8 | 0.98 | ||||
UHS | 11.7B | 14.3B | 16.37 | 0.82 | ||||
MID-CAP | ||||||||
CHE | 8.8B | 2.3B | 30.96 | 3.83 | ||||
ACHC | 6.3B | 3.0B | -553.66 | 2.09 | ||||
AMN | 2.3B | 3.8B | 10.82 | 0.6 | ||||
AMEH | 2.1B | 1.4B | 34.65 | 1.52 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.07 | 1.57 | ||||
BKD | 1.4B | 3.0B | -7.37 | 0.46 | ||||
BEAT | 54.0M | - | -3.69 | - | ||||
AMS | 19.6M | 21.3M | 36.7 | 0.92 |
Acadia Healthcare Co Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 3.4% | 768 | 743 | 750 | 731 | 704 | 675 | 667 | 652 | 617 | 593 | 588 | 582 | 551 | 541 | 548 | 491 | 509 | 501 | 509 | 510 | 488 |
Costs and Expenses | 1.0% | 669 | 663 | 1,038 | 635 | 619 | 587 | 570 | 542 | 537 | 497 | 502 | 517 | 522 | 465 | 502 | 455 | 484 | -251 | 728 | 730 | - |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 743 | 790 | 728 | 730 | 724 |
EBITDA Margin | 40.2% | 0.01* | 0.01* | 0.01* | 0.15* | 0.16* | 0.16* | 0.17* | 0.17* | 0.16* | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -32.9% | -27.21 | -20.47 | -20.74 | -20.91 | -20.00 | -19.40 | -18.00 | -16.57 | -15.79 | -15.57 | -15.71 | -16.69 | -29.03 | -39.71 | -37.31 | -38.52 | -42.56 | -43.94 | -46.64 | -48.61 | -48.13 |
Income Taxes | -0.7% | 20.00 | 20.00 | -71.87 | 23.00 | 19.00 | 25.00 | 24.00 | 28.00 | 17.00 | 25.00 | 17.00 | 19.00 | 6.00 | 16.00 | 9.00 | 9.00 | 6.00 | -0.72 | 7.00 | 12.00 | 7.00 |
Earnings Before Taxes | 23.6% | 99.00 | 80.00 | -287 | 96.00 | 86.00 | 88.00 | 97.00 | 110 | 79.00 | 96.00 | 85.00 | 65.00 | 29.00 | 76.00 | 46.00 | 37.00 | 25.00 | -10.25 | 50.00 | 60.00 | 37.00 |
EBT Margin | 53.1% | 0.00* | -0.01* | -0.01* | 0.13* | 0.14* | 0.14* | 0.15* | 0.15* | 0.14* | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 32.3% | 76.00 | 58.00 | -217 | 72.00 | 66.00 | 61.00 | 71.00 | 80.00 | 61.00 | 70.00 | 66.00 | 45.00 | 10.00 | -783 | 37.00 | 41.00 | 33.00 | -11.25 | 43.00 | 48.00 | 29.00 |
Net Income Margin | 49.0% | 0.00* | -0.01* | -0.01* | 0.10* | 0.10* | 0.10* | 0.11* | 0.11* | 0.10* | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -1968.3% | -463 | -22.42 | 10.00 | 73.00 | -22.12 | 26.00 | -35.31 | 67.00 | 26.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 3.0% | 5,517 | 5,359 | 5,346 | 5,150 | 5,044 | 4,988 | 4,943 | 4,883 | 4,835 | 4,768 | 4,595 | 4,564 | 4,527 | 6,499 | 7,105 | 6,833 | 6,718 | 6,879 | 6,728 | 6,790 | 6,786 |
Current Assets | 2.5% | 611 | 596 | 703 | 579 | 538 | 506 | 522 | 518 | 530 | 495 | 567 | 576 | 528 | 2,523 | 756 | 611 | 503 | 542 | 537 | 471 | 453 |
Cash Equivalents | -22.8% | 77.00 | 100 | 100 | 112 | 64.00 | 98.00 | 93.00 | 128 | 140 | 134 | 196 | 186 | 179 | 379 | 339 | 212 | 81.00 | 100 | 93.00 | 44.00 | 44.00 |
Inventory | 8.4% | 6.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | 4.8% | 2,376 | 2,267 | 2,146 | 2,074 | 1,998 | 1,952 | 1,909 | 1,857 | 1,796 | 1,771 | 1,665 | 1,651 | 1,655 | 1,623 | 3,254 | 3,161 | 3,152 | 1,500 | 3,131 | 3,164 | 3,173 |
Goodwill | 1.6% | 2,261 | 2,226 | 2,226 | 2,223 | 2,223 | 2,223 | 2,208 | 2,205 | 2,201 | 2,200 | 2,104 | 2,104 | 2,105 | 2,105 | 2,461 | 2,425 | 2,427 | 2,085 | 2,424 | 2,435 | 2,442 |
Liabilities | 2.9% | 2,542 | 2,471 | 2,536 | 2,139 | 2,114 | 2,087 | 2,111 | 2,144 | 2,190 | 2,185 | 2,098 | 2,149 | 2,172 | 4,545 | 4,444 | 4,296 | 4,220 | 4,341 | 4,275 | 4,336 | 4,350 |
Current Liabilities | -45.5% | 482 | 886 | 865 | 432 | 378 | 388 | 401 | 442 | 411 | 405 | 403 | 425 | 411 | 1,308 | 601 | 527 | 580 | 464 | 458 | 431 | 425 |
Long Term Debt | 33.6% | 1,794 | 1,343 | 1,350 | 1,372 | 1,400 | 1,365 | 1,379 | 1,384 | 1,464 | 1,479 | 1,413 | 1,443 | 1,484 | 2,969 | 3,067 | 3,078 | 2,945 | 3,105 | 3,134 | 3,207 | 3,222 |
LT Debt, Current | 110.3% | 61.00 | 29.00 | 27.00 | 24.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 19.00 | 16.00 | 13.00 | 12.00 | 153 | 51.00 | 48.00 | 196 | 44.00 | 41.00 | 39.00 | 37.00 |
LT Debt, Non Current | -100.0% | - | 1,343 | 1,350 | 1,372 | 1,400 | 1,365 | 1,379 | 1,384 | 1,464 | 1,479 | 1,413 | 1,443 | 1,484 | 2,969 | 3,067 | 3,078 | 2,945 | 3,105 | 3,134 | 3,207 | 3,222 |
Shareholder's Equity | 3.0% | 2,866 | 2,782 | 2,713 | 2,921 | 2,840 | 2,813 | 2,744 | 2,663 | 2,575 | 2,517 | 2,434 | 2,357 | 2,298 | 1,899 | 2,607 | 2,503 | 2,464 | 2,505 | 2,421 | 2,422 | 2,403 |
Retained Earnings | 58.0% | 208 | 132 | 74.00 | 292 | 219 | 153 | 92.00 | 21.00 | -58.91 | -119 | -190 | -256 | -300 | -310 | 473 | 436 | 395 | 362 | 373 | 330 | 282 |
Additional Paid-In Capital | 0.3% | 2,657 | 2,649 | 2,638 | 2,628 | 2,619 | 2,658 | 2,651 | 2,641 | 2,633 | 2,636 | 2,624 | 2,612 | 2,598 | 2,580 | 2,573 | 2,567 | 2,561 | 2,558 | 2,555 | 2,551 | 2,547 |
Accumulated Depreciation | 3.8% | 797 | 767 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 0.3% | 92.00 | 91.00 | 91.00 | 91.00 | 91.00 | 90.00 | 90.00 | 89.00 | 89.00 | 89.00 | 89.00 | 89.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 7,100 | - | - | - | 6,000 | - | - | - | 5,500 | - | - | - | 2,200 | - | - | - | 3,100 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -376.2% | -321 | 116 | 138 | 164 | 44.00 | 114 | 41.00 | 149 | 77.00 | 98.00 | 110 | 90.00 | 76.00 | 187 | 207 | 219 | 46.00 | 119 | 85.00 | 85.00 | 44.00 |
Share Based Compensation | -5.0% | 9.00 | 9.00 | 8.00 | 7.00 | 8.00 | 8.00 | 7.00 | 7.00 | 8.00 | 13.00 | 9.00 | 9.00 | 7.00 | 6.00 | 6.00 | 6.00 | 5.00 | 3.00 | 4.00 | 4.00 | 6.00 |
Cashflow From Investing | -67.6% | -184 | -110 | -129 | -90.77 | -66.91 | -92.02 | -78.02 | -86.09 | -49.69 | -230 | -74.23 | -50.28 | 1,368 | -72.18 | -69.72 | -65.77 | -74.16 | -63.95 | 41.00 | -67.88 | -110 |
Cashflow From Financing | 8644.9% | 483 | -5.65 | -21.07 | -24.66 | -11.32 | -17.29 | 2.00 | -75.11 | -20.54 | 70.00 | -25.12 | -33.57 | -1,647 | -2.93 | -12.55 | -22.58 | -13.43 | -29.47 | -74.71 | -15.95 | 59.00 |
Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 768,051 | $ 704,267 |
Salaries, wages and benefits (including equity-based compensation expense of $8,678 and $7,629, respectively) | 417,523 | 391,177 |
Professional fees | 45,688 | 41,125 |
Supplies | 26,652 | 26,021 |
Rents and leases | 11,863 | 11,424 |
Other operating expenses | 101,073 | 90,838 |
Depreciation and amortization | 36,347 | 31,569 |
Interest expense, net | 27,214 | 19,999 |
Transaction, legal and other costs | 2,847 | 6,471 |
Total expenses | 669,207 | 618,624 |
Income before income taxes | 98,844 | 85,643 |
Provision for income taxes | 20,074 | 19,085 |
Net income | 78,770 | 66,558 |
Net income attributable to noncontrolling interests | (2,387) | (543) |
Net income attributable to Acadia Healthcare Company, Inc. | $ 76,383 | $ 66,015 |
Earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: | ||
Basic | $ 0.84 | $ 0.73 |
Diluted | $ 0.83 | $ 0.72 |
Weighted-average shares outstanding: | ||
Basic | 91,363 | 90,101 |
Diluted | 92,010 | 91,391 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 77,303 | $ 100,073 |
Accounts receivable, net | 386,191 | 361,451 |
Other current assets | 147,312 | 134,476 |
Total current assets | 610,806 | 596,000 |
Property and equipment, net | 2,376,059 | 2,266,610 |
Goodwill | 2,261,026 | 2,225,962 |
Intangible assets, net | 73,352 | 73,278 |
Deferred tax assets | 2,777 | 6,658 |
Operating lease right-of-use assets | 121,346 | 117,780 |
Other assets | 71,881 | 72,553 |
Total assets | 5,517,247 | 5,358,841 |
Current liabilities: | ||
Current portion of long-term debt | 61,452 | 29,219 |
Accounts payable | 156,130 | 156,132 |
Accrued salaries and benefits | 118,005 | 141,901 |
Current portion of operating lease liabilities | 26,815 | 26,268 |
Other accrued liabilities | 119,911 | 532,261 |
Total current liabilities | 482,313 | 885,781 |
Long-term debt | 1,794,296 | 1,342,548 |
Deferred tax liabilities | 15,527 | 1,931 |
Operating lease liabilities | 103,352 | 100,808 |
Other liabilities | 146,404 | 140,113 |
Total liabilities | 2,541,892 | 2,471,181 |
Redeemable noncontrolling interests | 109,333 | 105,686 |
Equity: | ||
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued | ||
Common stock, $0.01 par value; 180,000,000 shares authorized; 91,573,596 and 91,263,989 issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 916 | 913 |
Additional paid-in capital | 2,657,002 | 2,649,340 |
Retained earnings | 208,104 | 131,721 |
Total equity | 2,866,022 | 2,781,974 |
Total liabilities and equity | $ 5,517,247 | $ 5,358,841 |